Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily

ClinicalTrials.gov ID: NCT00634842

Public ClinicalTrials.gov record NCT00634842. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 10:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect of Two Different Fasting Blood Glucose Titration Targets in Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily in Combination With 1-3 Oral Agents

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in the United States of America. The aim of this trial is to explore how different fasting blood glucose targets affect glucose control in patients with type 2 diabetes, when patients are empowered to do dose adjustments themselves.

Study identification

NCT ID
NCT00634842
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
244 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2008 (Type not available)
Primary completion
Oct 2008 (Actual)
Completion
Oct 2008 (Actual)
Last update posted
Mar 10, 2017

2008

United States locations

U.S. sites
66
U.S. states
28
U.S. cities
58
Facility City State ZIP Site status
Novo Nordisk Investigational Site Goodyear Arizona 85395 —
Novo Nordisk Investigational Site Scottsdale Arizona 85251-5638 —
Novo Nordisk Investigational Site Searcy Arkansas 72143 —
Novo Nordisk Investigational Site Artesia California 90701 —
Novo Nordisk Investigational Site Escondido California 92025 —
Novo Nordisk Investigational Site Fullerton California 92835-3404 —
Novo Nordisk Investigational Site Los Angeles California 90036 —
Novo Nordisk Investigational Site Los Angeles California 90057 —
Novo Nordisk Investigational Site Orange California 92869 —
Novo Nordisk Investigational Site Spring Valley California 91978 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Parker Colorado 80138-8789 —
Novo Nordisk Investigational Site Norwalk Connecticut 06851 —
Novo Nordisk Investigational Site Prospect Connecticut 06712 —
Novo Nordisk Investigational Site Boca Raton Florida 33433 —
Novo Nordisk Investigational Site Clearwater Florida 33755-2138 —
Novo Nordisk Investigational Site Jacksonville Florida 32204 —
Novo Nordisk Investigational Site Jacksonville Florida 32205 —
Novo Nordisk Investigational Site Jacksonville Florida 32216 —
Novo Nordisk Investigational Site Lake Mary Florida 32746 —
Novo Nordisk Investigational Site Plantation Florida 33324 —
Novo Nordisk Investigational Site Athens Georgia 30606 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Savannah Georgia 31406 —
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596 —
Novo Nordisk Investigational Site Chicago Illinois 60607 —
Novo Nordisk Investigational Site Terre Haute Indiana 47802 —
Novo Nordisk Investigational Site Topeka Kansas 66606 —
Novo Nordisk Investigational Site New Orleans Louisiana 70121 —
Novo Nordisk Investigational Site Pikesville Maryland 21208-3737 —
Novo Nordisk Investigational Site Saint Paul Minnesota 55108 —
Novo Nordisk Investigational Site Chesterfield Missouri 63017-3632 —
Novo Nordisk Investigational Site St Louis Missouri 63141 —
Novo Nordisk Investigational Site Omaha Nebraska 68114 —
Novo Nordisk Investigational Site Las Vegas Nevada 89101 —
Novo Nordisk Investigational Site Berlin New Jersey 08009 —
Novo Nordisk Investigational Site Camden New Jersey 08104 —
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648 —
Novo Nordisk Investigational Site New York New York 10023 —
Novo Nordisk Investigational Site Staten Island New York 10301 —
Novo Nordisk Investigational Site West Seneca New York 14224 —
Novo Nordisk Investigational Site Shelby North Carolina 28152 —
Novo Nordisk Investigational Site Statesville North Carolina 28625 —
Novo Nordisk Investigational Site Cincinnati Ohio 45245 —
Novo Nordisk Investigational Site Dayton Ohio 45406 —
Novo Nordisk Investigational Site Dayton Ohio 45439 —
Novo Nordisk Investigational Site Mentor Ohio 44060 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73103 —
Novo Nordisk Investigational Site Altoona Pennsylvania 16602 —
Novo Nordisk Investigational Site Norristown Pennsylvania 19401 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19104 —
Novo Nordisk Investigational Site Spartanburg South Carolina 29303 —
Novo Nordisk Investigational Site Taylors South Carolina 29687 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37404 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37411 —
Novo Nordisk Investigational Site Arlington Texas 76014 —
Novo Nordisk Investigational Site Dallas Texas 75231 —
Novo Nordisk Investigational Site Dallas Texas 75390-9302 —
Novo Nordisk Investigational Site Houston Texas 77024 —
Novo Nordisk Investigational Site Houston Texas 77025 —
Novo Nordisk Investigational Site Midland Texas 79707 —
Novo Nordisk Investigational Site Odessa Texas 79761 —
Novo Nordisk Investigational Site San Antonio Texas 78209 —
Novo Nordisk Investigational Site Spokane Washington 99204-2629 —
Novo Nordisk Investigational Site Spokane Washington 99218 —
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00634842, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 10, 2017 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00634842 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →